Patterns of failure after complete resection of thoracic esophageal squamous cell carcinoma:implications for postoperative radiation therapy volumes
ZHANG Wen-cheng*, WAGN Qi-feng, XIAO Ze-fen, YANG Long-hai, LIU Xiong-yang
*Department of Radiation Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China
Abstract：Objective To analyze intrathoracic or extrathoracic recurrence pattern after surgical resection of thoracic esophageal squamous cell carcinoma (TESCC) and its help for further modify and improvement on the target of postoperative radiation therapy. Methods One hundred and ninety-five patients who had undergone resection of TESCC at the Cancer Hospital, Chinese Academy of Medical Sciences enrolled from April 1999 to July 2007. Sites of failure on different primary location of esophageal cancer were documented. Results Patients with upper or middle thoracic esophageal cancer had higher proportion of intrathoracic recurrence. Patients with lower thoracic esophageal cancer had more intrathoracic reccurence and abdominal lymph node metastatic recurrence. Histological lymph node status has nothing to do with intrathoracic recurrence, supraclavicular lymph node (SLN) metastasis or distant metastasis (χ2=1.58,0.06,0.04,P=0.134,0.467,0.489, respectively), whereas the chance of abdominal lymph node metastases in N positive patients was significantly higher than that in N0 patients (28.7%∶10.6%,χ2=9.94,P=0.001), and so did in middle thoracic esophageal cancer (20.0%∶5.6%,χ2=5.67,P=0.015). Anatomic recurrence rate of patients with proximal resection margin no more than 3 cm was significantly higher compared to those more than 3 cm (25.0%∶11.3%,χ2=5.65,P=0.019). Conclusions Mediastinum is the most common recurrence site. According to recurrence site, the following radiation targets are recommended:when tumor was located at the upper or middle thoracic esophagus with negative N status, the mediastinum, the tumor bed and the supraclavicular region should be included as postoperative RT target;when tumor was located at the middle thoracic esophagus with positive N or located at the lower thoracic esophagus, the abdominal lymph node should be added. If the proximal resection margin was no more than 3 cm, the anastomotic-stoma should be included.
ZHANG Wen-cheng*,WAGN Qi-feng,XIAO Ze-fen et al. Patterns of failure after complete resection of thoracic esophageal squamous cell carcinoma:implications for postoperative radiation therapy volumes[J]. Chinese Journal of Radiation Oncology, 2012, 21(1): 38-41.
[1] Doki Y, Ishikawa O, Takachi K, et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg,2005,29:700-707. [2] Law SY, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer:clinical implications. Br J Surg,1996,83:107-111. [3] Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg,2000,87:1426-1433. [4] Fok M, Sham JS, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus:a prospective, randomized controlled study. Surgery,1993,113:138-147. [5] Tachibana M, Yoshimura H, Kinugasa S, et al. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer:a prospective randomized clinical trial. Eur J Surg Oncol,2003,29:580-587. [6] Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma:a report of 495 patients. Ann Thorac Surg,2003,75:331-336. [7] Chen J, Pan J, Zheng X, et al. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys,2011,In press. [8] Qiao XY, Wang W, Zhou ZG, et al. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys,2008,70:396-402. [9] Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology,1991,48:411-420. [10] Cai WJ, Xin PL. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy. Radiother Oncol,2010,96:104-107. [11] Gao XS, Qiao X, Wu F, et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys,2007,67:389-396.
2012, Vol. 21 
